The appropriate dimensions of protection for intellectual property rights in general, and patents in particular, have been matters of controversy since the 16th century. Software and biotechnology, both relatively new areas to come under the patent umbrella, have brought the debate to a fevered pitch in recent years. The Joint Center has invited leading scholars to illuminate the issues for these two industries, which are so closely identified with innovation in high technology.
